ClinicalTrials.gg
Not yet recruitingNCT07576569ADAPT-CABGUpdated May 8, 2026

Nursing Intervention for Adaptation After Myocardial Revascularization

An interventional study of Nursing Intervention Program and Usual Care in Coronary Artery Disease, Myocardial Revascularization and Postoperative Recovery After Cardiac Surgery, sponsored by Universidad de la Sabana. Not yet recruiting at 1 site in Colombia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Universidad de la Sabana · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 15 studies in Coronary Artery Disease with a site in Colombia — 2 open to participants now, 3 under way, 1 of them phase 3. Coronary Artery Disease · Colombia.

Planned enrollment
9th of 11
40 · median 70
Started
2027
the only one that year
No phase
Only one
of the 15
Registered
15th of 15
by date

Among the 15 studies in Coronary Artery Disease with a site in Colombia, this one is the 9th largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2027, is the only one with no phase, and was the 15th registered.

Coronary Artery Disease

4,866 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.

Browse Coronary Artery Disease studies →

Open to participants now

2 of the 15 studies in Coronary Artery Disease with a site in Colombia are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Colombia have not opened yet or have stopped. Only those recruiting at a site in Colombia →

Who these studies take

Of the 591 Coronary Artery Disease studies recruiting now, 404 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Coronary Artery Disease with a site in Colombia, or all of them as a file.
02

Study summary

Introduction: Myocardial revascularization is an essential procedure for patients with cardiovascular disease. Its recovery in the outpatient setting involves significant challenges for both the patient and the caregiver. This recovery phase may generate physical, emotional, and psychological complications that require an effective adaptation process of the patient-caregiver dyad to ensure successful recovery and improved quality of life.

Objective: To evaluate the preliminary effectiveness of a nursing intervention aimed at improving adaptation in the patient-caregiver dyad during the outpatient postoperative period following myocardial revascularization, compared with usual care, in Bucaramanga during the period 2026-2027.

Materials and Methods: A pilot randomized controlled trial will be conducted to develop and evaluate a novel nursing intervention aimed at promoting adaptation in patients undergoing outpatient postoperative myocardial revascularization and their caregivers. The intervention will be designed and its feasibility, acceptability, and preliminary effectiveness will be assessed. Data analysis will be performed using descriptive and inferential statistical methods, considering the distribution and behavior of the data.

Expected Results: The study is expected to assess the preliminary effectiveness of the proposed intervention through the integration of theoretical and empirical components.

03

Conditions studied

  • Coronary Artery Disease
  • Myocardial Revascularization
  • Postoperative Recovery After Cardiac Surgery
  • Nursing Care

Keywords

  • Myocardial Revascularization
  • Nursing Intervention
  • Patient-Caregiver Dyad
  • Adaptation
  • Postoperative Recovery
  • Cardiovascular Disease
  • Randomized Controlled Trial
  • Outpatient Care
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older who have undergone myocardial revascularization surgery, completed the immediate postoperative in-hospital period without major complications, and have been discharged for outpatient management according to institutional protocols
  • Patients who, at the time of discharge, do not require ventilatory support, invasive hemodynamic support, or continuous monitoring, and present documented clinical stability
  • Presence of an identified primary caregiver actively involved in the home care process during the outpatient postoperative period
  • Preserved cognitive capacity in both patient and caregiver, allowing understanding of instructions, participation in the intervention, and completion of assessment instruments
  • Written provided by both patient and caregiver

Exclusion criteria

Exclusion Criteria:

  • Patients presenting severe postoperative complications, such as deep surgical site infection, persistent hemodynamic instability, major neurological events, or readmission to the intensive care unit at the start of the intervention Patients with moderate to severe cognitive impairment, decompensated psychiatric disorders, or neurological conditions that limit understanding, communication, or active participation
  • Caregivers with physical, cognitive, or emotional limitations that compromise the effective performance of the caregiving role during the follow-up period
  • Patients without a clearly identified support network or without an available primary caregiver to participate in the study
  • Concurrent participation in other clinical, educational, or psychosocial intervention studies that may interfere with the proposed intervention
  • Language or cultural barriers that prevent understanding of the intervention content or interaction with the research team, without adequate mediation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Nursing Intervention

    Participants will receive a structured nursing intervention based on the Roy Adaptation Model, including education, emotional support, and follow-up during the 30-day outpatient postoperative period following myocardial revascularization.

    Behavioral: Nursing Intervention Program

  • Active comparator
    Usual Care

    Participants will receive standard postoperative care without the structured nursing intervention.

    Other: Usual Care

Interventions

  • BehavioralNursing Intervention Program

    Structured nursing intervention focused on improving adaptation in the patient-caregiver dyad through education, emotional support, and follow-up care.

  • OtherUsual Care

    Participants will receive standard postoperative care without the structured nursing intervention.

06

What researchers measure

Primary outcomes

  1. Adaptation level in the patient-caregiver dyad

    Adaptation will be assessed using validated instruments that measure dimensions related to the Roy Adaptation Model, including physiological, self-concept, role function, and interdependence domains in both patient and caregiver.

    Time frame: Baseline and 30 days post-discharge

07

Study locations

1 site
  • Universidad de La Sabana
    Bogotá, Bogota D.C. 250001, Colombia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Aug 2027, 7 months later.

Of 756 non-industry interventional studies with no phase under Coronary Artery Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's planned 7 months is below that.

Counting every sponsor, half of 933 studies reached it within 30 months; a quarter within 15 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
May 2, 2026
First posted
May 8, 2026
StartEst.
Jan 2027
Primary completionEst.
Aug 2027
CompletionEst.
Dec 2027
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07576569
Lead sponsor
Universidad de la Sabana
Responsible party
Sponsor
First posted
May 8, 2026
Start date
Jan 2027 (estimated)
Primary completion
Aug 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
May 8, 2026

Study contacts

Débora Milena Alvarez Yañez, PhD(c)
Contact
deboraalya@unisabana.edu.co
+57 3112323289
Gloria Carvajal Carrascal, PhD
Contact
gloria.carvajal@unisabana.edu.co
+57 3115062590
Alvarez Yañez
principal investigator · Universidad de la Sabana

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion